Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Avanos Medical (AVNS) Interest Expenses (2016 - 2026)

Avanos Medical's Interest Expenses history spans 13 years, with the latest figure at $1.9 million for Q4 2025.

  • On a quarterly basis, Interest Expenses fell 32.14% to $1.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.8 million, a 36.07% decrease, with the full-year FY2025 number at $7.8 million, down 36.07% from a year prior.
  • Interest Expenses hit $1.9 million in Q4 2025 for Avanos Medical, up from $1.8 million in the prior quarter.
  • Over the last five years, Interest Expenses for AVNS hit a ceiling of $4.7 million in Q3 2023 and a floor of $700000.0 in Q4 2021.
  • Historically, Interest Expenses has averaged $2.4 million across 5 years, with a median of $2.8 million in 2022.
  • Biggest five-year swings in Interest Expenses: crashed 81.4% in 2021 and later surged 328.57% in 2022.
  • Tracing AVNS's Interest Expenses over 5 years: stood at $700000.0 in 2021, then surged by 328.57% to $3.0 million in 2022, then increased by 10.0% to $3.3 million in 2023, then dropped by 15.15% to $2.8 million in 2024, then tumbled by 32.14% to $1.9 million in 2025.
  • Business Quant data shows Interest Expenses for AVNS at $1.9 million in Q4 2025, $1.8 million in Q3 2025, and $2.0 million in Q2 2025.